Jing Niu

Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers

A. Gautam, S. Munjal, M. Gopalakrishnan, 2017, Clinical Drug Investigation.

Parent‐Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT‐888), a PARP Inhibitor, in Patients With BRCA 1/2–Mutated Cancer or PARP‐Sensitive Tumor Types

V. Ivaturi, J. Gobburu, E. Chu, 2017, Journal of clinical pharmacology.